MedPath

RENAGEL

RENAGEL

Discontinued
DIN Number

02244309

Drug Class

Human

Market Date

Nov 21, 2001

Company
HC

sanofi genzyme, a division of sanofi-aventis canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02244309
AIG Number0139865001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
V03AE02 SEVELAMER
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification40:18.19
Health Canada Classification

ACTIVE INGREDIENTS (1)

SEVELAMER HYDROCHLORIDEActive
Strength: 400 MG
Monograph: SEVELAMER HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.